Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.39 | N/A |
| PEG Ratio (TTM) | -0.56 | N/A |
| P/S Ratio (TTM) | 1.85 | N/A |
| P/B Ratio (TTM) | 1.54 | N/A |
| P/FCF Ratio (TTM) | 8.83 | N/A |
| Price to 5YR AVG Earnings Ratio | 15.23 | N/A |
| Price to 5YR AVG FCF Ratio | 10.98 | N/A |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 10.16% | N/A |
| ROE (TTM) | 11.73% | N/A |
| Net Profit Margin (TTM) | 13.80% | N/A |
| ROIC 5YR AVG | 13.88% | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -23.67% | -5.33% | 7.81% |
| Revenue | -26.25% | 0.93% | 1.61% |
| Net Income | 0.80% | -4.84% | 7.75% |
| Cash Flow | 4.50% | -0.09% | 7.94% |
Health (84%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 6.27 | N/A |
| Quick Ratio (TTM) | 5.03 | N/A |
| D/E Ratio (TTM) | 0.01 | N/A |
| Interest Coverage (TTM) | 12.16 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 9.46 | N/A |
| LTL to 5YR AVG FCF | 0.20 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.01% | N/A |